Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice
- PMID: 1584223
- DOI: 10.1210/mend.6.4.1584223
Conversion of bovine growth hormone cysteine residues to serine affects secretion by cultured cells and growth rates in transgenic mice
Abstract
GHs have been found to possess two disulfide bonds. We set out to determine the importance of bovine (b) GH's disulfide bonds relative to the ability of the hormone to be secreted by cultured cells in vitro and to promote growth in transgenic mice. We have generated six mutated bGH genes that encode serine (Ser) substitutions for cysteines (Cys). These mutated genes were used to generate bGH analogs in which either one or both disulfide bonds are destroyed. When the small loop of bGH was destroyed (Cys181-Ser or Cys189-Ser), the bGH analogs were found to be secreted by mouse L-cells at levels comparable to those of wild-type bGH. However, secretion was drastically reduced when the large loop was abolished (Cys53-Ser or Cys164-Ser). An immunofluorescence study of these bGH analogs revealed two distinct patterns of subcellular localization. Bovine GH analogs with mutations in the small loop demonstrated a perinuclear distribution similar to that of wild-type bGH, but analogs containing a disrupted large loop revealed a uniform cytoplasmic distribution pattern. When these mutated bGH genes were individually introduced into transgenic mice, only those animals that expressed bGH analogs with the large loop intact demonstrated a growth-enhanced phenotype. Transgenic mice that expressed bGH analogs lacking the large loop showed growth rates similar to those of nontransgenic mice. These results suggest that the integrity of the large loop, but not that of the small loop, is essential for the growth-enhancing activity of bGH in transgenic mice.
Similar articles
-
Amino acid residues in the third alpha-helix of growth hormone involved in growth promoting activity.Mol Endocrinol. 1995 Mar;9(3):292-302. doi: 10.1210/mend.9.3.7539887. Mol Endocrinol. 1995. PMID: 7539887
-
Functional antagonism between endogenous mouse growth hormone (GH) and a GH analog results in dwarf transgenic mice.Endocrinology. 1991 Sep;129(3):1402-8. doi: 10.1210/endo-129-3-1402. Endocrinology. 1991. PMID: 1874179
-
In-vitro mutagenesis of the bovine growth hormone gene.J Reprod Fertil Suppl. 1990;41:25-35. J Reprod Fertil Suppl. 1990. PMID: 2213712
-
Growth hormone (GH) binding and effects of GH analogs in transgenic mice.Proc Soc Exp Biol Med. 1994 Jul;206(3):190-4. doi: 10.3181/00379727-206-43740. Proc Soc Exp Biol Med. 1994. PMID: 8016152 Review.
-
Glomerulosclerosis in mice transgenic for native or mutated bovine growth hormone gene.Kidney Int Suppl. 1993 Jan;39:S90-4. Kidney Int Suppl. 1993. PMID: 8468934 Review.
Cited by
-
Acromegaly pathogenesis and treatment.J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009 Nov 2. J Clin Invest. 2009. PMID: 19884662 Free PMC article. Review.
-
Diabetes in patients with acromegaly treated with pegvisomant: observations from acrostudy.Endocrine. 2019 Mar;63(3):563-572. doi: 10.1007/s12020-018-1792-0. Epub 2018 Nov 24. Endocrine. 2019. PMID: 30474822 Free PMC article.
-
Short stature explained by dimerization of human growth hormone induced by a p.C53S point mutation.J Biol Chem. 2020 Apr 10;295(15):4893-4901. doi: 10.1074/jbc.RA119.009101. Epub 2020 Mar 4. J Biol Chem. 2020. PMID: 32132170 Free PMC article.
-
Differential in vivo activities of bovine growth hormone analogues.Transgenic Res. 1998 Jan;7(1):61-71. doi: 10.1023/a:1008808106353. Transgenic Res. 1998. PMID: 9556914
-
Genetic variation at the growth hormone (GH1) and growth hormone receptor (GHR) loci as a risk factor for hypertension and stroke.Hum Genet. 2006 Jun;119(5):527-40. doi: 10.1007/s00439-006-0166-5. Epub 2006 Mar 30. Hum Genet. 2006. PMID: 16572267
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases